Protection against Omicron BA.2 reinfection conferred by primary Omicron or pre-Omicron infection with and without mRNA vaccination
View ORCID ProfileSara Carazo, View ORCID ProfileDanuta M. Skowronski, View ORCID ProfileMarc Brisson, Sapha Barkati, Chantal Sauvageau, Nicholas Brousseau, Rodica Gilca, Judith Fafard, Denis Talbot, Manale Ouakki, Vladimir Gilca, Alex Carignan, Geneviève Deceuninck, Philippe De Wals, View ORCID ProfileGaston De Serres
doi: https://doi.org/10.1101/2022.06.23.22276824
Sara Carazo
1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada
MD PhDDanuta M. Skowronski
2Communicable Diseases and Immunization Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada
MD FRCPCMarc Brisson
3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada
4Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada
PhDSapha Barkati
5Department of Medicine, Division of infectious diseases, McGill University Health Center, McGill University, Montreal, Quebec, Canada
MDChantal Sauvageau
1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada
3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada
4Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada
MDNicholas Brousseau
1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada
3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada
4Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada
MD MScRodica Gilca
1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada
3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada
4Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada
MD PhDJudith Fafard
6Laboratoire de Santé Publique du Québec, Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Quebec, Canada
MDDenis Talbot
3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada
4Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada
PhDManale Ouakki
1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada
MScVladimir Gilca
1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada
MDAlex Carignan
7Department of microbiology and infectious diseases, Sherbrook University, Sherbrook, Quebec, Canada
MDGeneviève Deceuninck
3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada
MDPhilippe De Wals
1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada
3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada
4Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada
MD PhDGaston De Serres
1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada
3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada
4Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada
MD PhDData Availability
The databases used in this study are a property of the Mininstry of Health of Quebec and were shared with the researchers under the legal mandate of the National Director of Public Health of Quebec under the Public Health Act, preventing data sharing with a third party. Aggregate data are available within the manuscript and the supplementary material.
Posted June 27, 2022.
Protection against Omicron BA.2 reinfection conferred by primary Omicron or pre-Omicron infection with and without mRNA vaccination
Sara Carazo, Danuta M. Skowronski, Marc Brisson, Sapha Barkati, Chantal Sauvageau, Nicholas Brousseau, Rodica Gilca, Judith Fafard, Denis Talbot, Manale Ouakki, Vladimir Gilca, Alex Carignan, Geneviève Deceuninck, Philippe De Wals, Gaston De Serres
medRxiv 2022.06.23.22276824; doi: https://doi.org/10.1101/2022.06.23.22276824
Protection against Omicron BA.2 reinfection conferred by primary Omicron or pre-Omicron infection with and without mRNA vaccination
Sara Carazo, Danuta M. Skowronski, Marc Brisson, Sapha Barkati, Chantal Sauvageau, Nicholas Brousseau, Rodica Gilca, Judith Fafard, Denis Talbot, Manale Ouakki, Vladimir Gilca, Alex Carignan, Geneviève Deceuninck, Philippe De Wals, Gaston De Serres
medRxiv 2022.06.23.22276824; doi: https://doi.org/10.1101/2022.06.23.22276824
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (695)
- Anesthesia (186)
- Cardiovascular Medicine (2809)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12499)
- Forensic Medicine (10)
- Gastroenterology (796)
- Genetic and Genomic Medicine (4364)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2813)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (411)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4131)
- Nursing (219)
- Nutrition (613)
- Oncology (2178)
- Ophthalmology (616)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (480)
- Public and Global Health (6720)
- Radiology and Imaging (1475)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (197)
- Urology (173)